Activated protein C cofactor function of protein S: A novel role for a γ-carboxyglutamic acid residue

Blood

Volumn 117, Issue 24, 2011, Pages 6685-6693

  Ahnström, Josefin ^a   Andersson, Helena M ^a   Canis, Kevin ^b   Norstrøm, Eva ^c   Yu, Yao ^a   Dahlbäck, Björn ^c   Panico, Maria ^b   Morris, Howard R ^b   Crawley, James T B ^a   Lane, David A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBOXYGLUTAMIC ACID; ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5A; EPIDERMAL GROWTH FACTOR; PHOSPHOLIPID; PHOSPHOLIPID BINDING PROTEIN; PROTEIN S;

ARTICLE; CONTROLLED STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN VARIANT;

EID: 79959187738     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-11-317099     Document Type: Article

References (44)

1. Dahlback B, Villoutreix BO. The anticoagulant protein C pathway. FEBS Lett. 2005;579(15): 3310-3316. (Pubitemid 40804679)
2. Hackeng TM, Sere KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A. 2006;103(9):3106-3111. (Pubitemid 43346432)
3. Ndonwi M, Broze G Jr. Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa-tissue factor. J Thromb Haemost. 2008;6(6):1044-1046. (Pubitemid 351689932)
4. Makris M, Leach M, Beauchamp NJ, et al. Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood. 2000;95(6):1935-1941. (Pubitemid 30151629)
5. ten Kate MK, van der Meer J. Protein S deficiency: a clinical perspective. Haemophilia. 2008; 14(6):1222-1228.
6. Brouwer JL, Lijfering WM, ten Kate MK, et al. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Thromb Haemost. 2009;101(1):93-99.
7. Simmonds RE, Ireland H, Lane DA, et al. Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect. Ann Intern Med. 1998;128(1):8-14. (Pubitemid 28016712)
8. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest. 1984;74(6): 2082-2088. (Pubitemid 15197352)
9. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood. 1984;64(6):1297-1300. (Pubitemid 15224546)
10. Burstyn-Cohen T, Heeb MJ, Lemke G. Lack of Protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J Clin Invest. 2009;119(10):2942-2953.
11. Saller F, Brisset AC, Tchaikovski SN, et al. Generation and phenotypic analysis of protein S-deficient mice. Blood. 2009;114(11):2307-2314.
12. Dahlback B, Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci U S A. 1981;78(4):2512-2516. (Pubitemid 11048838)
13. Rezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood. 2004;103(4):1192-1201. (Pubitemid 38168627)
14. Dahlback B. The tale of protein S and C4b-binding protein, a story of affection. Thromb Haemost. 2007; 98(1):90-96. (Pubitemid 47074183)
15. Maurissen LF, Thomassen MC, Nicolaes GA, et al. Re-evaluation of the role of the protein SC4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood. 2008; 111(6):3034-3041.
16. Hansson K, Stenflo J. Post-translational modifications in proteins involved in blood coagulation. J Thromb Haemost. 2005;3(12):2633-2648. (Pubitemid 41819790)
17. Grinnell BW, Walls JD, Marks C, et al. Gamma-carboxylated isoforms of recombinant human protein S with different biologic properties. Blood. 1990;76(12):2546-2554.
18. Stenflo J, Stenberg Y, Muranyi A. Calcium-binding EGF-like modules in coagulation proteinases: function of the calcium ion in module interactions. Biochim Biophys Acta. 2000;1477(1):51-63. (Pubitemid 30119891)
19. Villoutreix BO, Teleman O, Dahlback B. A theoretical model for the Gla-TSR-EGF-1 region of the anticoagulant cofactor protein S: from biostructural pathology to species-specific cofactor activity. J Comput Aided Mol Des. 1997;11(3): 293-304. (Pubitemid 127506737)
20. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994;269(50):31869-31880. (Pubitemid 24379561)
21. Rosing J, Hoekema L, Nicolaes GA, et al. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem. 1995;270(46):27852-27858.
22. Norstrom EA, Steen M, Tran S, Dahlback B. Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va. J Biol Chem. 2003;278(27):24904-24911. (Pubitemid 37548650)
23. Yegneswaran S,Wood GM, Esmon CT, JohnsonAE. Protein S alters the active site location of activated protein C above the membrane surface: a fluorescence resonance energy transfer study of topography. J Biol Chem. 1997;272(40):25013- 25021. (Pubitemid 27415681)
24. Tran S, Dahlback B. Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S. J Thromb Haemost. 2010;8(1):129-136.
25. Dahlback B, Hildebrand B, Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem. 1990;265(14):8127-8135.
26. Mille-Baker B, Rezende SM, Simmonds RE, et al. Deletion or replacement of the second EGF-like domain of protein S results in loss of APC cofactor activity. Blood. 2003;101(4):1416-1418. (Pubitemid 36182514)
27. Van Wijnen M, Stam JG, Chang GT, et al. Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain. Biochem J. 1998;330(1): 389-396. (Pubitemid 28075766)
28. He X, Shen L, Villoutreix BO, Dahlback B. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function. J Biol Chem. 1998;273(42):27449-27458. (Pubitemid 28500463)
29. Saller F, Villoutreix BO, Amelot A, et al. The gamma-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding. Blood. 2005;105(1):122-130. (Pubitemid 40053073)
30. Andersson HM, Arantes MJ, Crawley JT, et al. Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain. Blood. 2010;115(23):4878-4885.
31. Rezende SM, Razzari C, Simmonds RE. In vitro high level protein S expression after modification of protein S cDNA. Thromb Haemost. 2003;90(6): 1214-1215. (Pubitemid 38004446)
32. Lorand L, Mann KG. Proteolytic enzymes in coagulation, fibrinolysis, and complement activation. Part A. In: Mammalian Blood Coagulation Factors and Inhibitors. San Diego, CA: Academic Press; 1993.
33. Tran S, Norstrom E, Dahlback B. Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va. J Biol Chem. 2008;283(11):6648-6655.
34. Krisinger MJ, Guo LJ, Salvagno GL, et al. Mouse recombinant protein C variants with enhanced membrane affinity and hyper-anticoagulant activity in mouse plasma. FEBS J. 2009;276(22): 6586-6602.
35. Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem. 1994; 269(29):18735-18738. (Pubitemid 24226180)
36. Evenäs P, Garcia de Frutos P, Nicolaes GA, Dahlback B. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa. Thromb Haemost. 2000;84(2):271-277. (Pubitemid 30601474)
37. Mori Y, Hamuro T, Nakashima T, et al. Biochemical characterization of plasma-derived tissue factor pathway inhibitor: post-translational modification of free, full-length form with particular reference to the sugar chain. J Thromb Haemost. 2009;7(1):111-120.
38. Sere KM, Janssen MP, Willems GM, et al. Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity. Biochemistry. 2001;40(30):8852-8860. (Pubitemid 32709518)
39. Sere KM, Willems GM, Rosing J, Hackeng TM. Protein S multimers are generated in vitro and affect protein S structure-function analyses. Semin Hematol. 2006;43(1 suppl 1):S111-S120. (Pubitemid 43150513)
40. Walker FJ. Regulation of activated protein C by a new protein: a possible function for bovine protein S. J Biol Chem. 1980;255(12):5521-5524.
41. Hansson K, Thamlitz AM, Furie B, Furie BC, Stenflo J. A single gamma-carboxyglutamic acid residue in a novel cysteine-rich secretory protein without propeptide. Biochemistry. 2006;45(42): 12828-12839. (Pubitemid 44630869)
42. Czerwiec E, Kalume DE, Roepstorff P, et al. Novel gamma-carboxyglutamic acid-containing peptides from the venom of Conus textile. FEBS J. 2006;273(12):2779-2788.
43. Yao Y, Shahbazian A, Bostrom KI. Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4. Circ Res. 2008;102(9): 1065-1074. (Pubitemid 351667860)
44. Fernandez-Fernandez L, Bellido-Martin L, Garcia de Frutos P. Growth arrest-specific gene 6 (GAS6): an outline of its role in haemostasis and inflammation. Thromb Haemost. 2008;100(4): 604-610.